24/7 Customer Support

+1 718 473 0872

Biosimilars Industry

Biosimilars and their Contribution to Increasing Patient Access to Essential Medicines

  • May 2011
  • 20 pages

Download This Report Now!

We value your privacy and will never rent or sell your email address.
Privacy Policy by TRUSTe

  • Segment Coverage

    Generic Drug  

    Biosimilars  

  • Geographic Coverage

    Europe  

    Germany  

    United States  

    United Kingdom  

  • Biosimilars and their contribution to increasing patient access to essential
  • medicines 1
  • Basel, May 20, 2011 1
  • At Sandoz/Novartis, innovative and follow-on biologics are developed and
  • manufactured in the same cutting edge facilities 2
  • Biosimilars are systematically developed to match the molecular attributes of
  • the reference product 3
  • Variability is significant in original biological products 4
  • Growing demand drives costs. and threatens to limit patient access (US example) 5
  • $63 billion in global biologics sales will be off patent by 2016 7
  • Europe: German example shows immediate savings from biosimilars - and huge
  • potential 8
  • UK example: Biosimilars expand access to GCSF 9
  • Genuine competition - with a ?level playing field? for all biologics - will lead
  • to increased innovation 11
  • Backup slides 12
  • Pharmacovigilance and naming 13
  • Biologics are more complex than small molecules. 15
  • Biosimilars development requires substantive investment and time 17
  • Sandoz is the world leader in developing, manufacturing and commercializing
  • biosimilars 18
  • Unique position within Novartis provides powerful and entrenched - competitive
  • advantage 19
  • Sandoz biosimilars: #1 with 3 marketed products 20
  • Estimated daily treatment costs 5
  • By 2016, 7 of the top 10 pharmaceuticals worldwide will be biologics, driving up
  • healthcare costs 6
  • WW Biologics sales 7
  • EPO market in Germany: Effect of biosimilar market entry, 8
  • UK G-CSF volume growth 9
  • Sandoz drove leading market share for Zarzio in Sweden while increasing patient
  • access 10
  • What is a biosimilar (or follow-on biologic)? 14
  • Biosimilars are recognized around the world as safe and effective medicines 16

Refine your search results

Additional Related Reports

Biosimilars Market Forecast in Europe

  • After Generics It's the Turn of Biosimilars, a Budding Market
  • September 2014
    2 pages
  • Biosimilars  

    Drug  

  • Europe  

    Spain  

    World  

View report >

Biosimilar market shares - Forecast

  • January 2014
    3 pages
  • Biosimilar  

  • India  

    Europe  

View report >

Biosimilars Market Share in Europe - Forecast

  • Executive Summary
  • January 2014
    2 pages
  • Biosimilars  

  • Spain  

    Europe  

    Germany  

View report >

Drug Industry

8 months ago

Related Market Segments :

Biosimilars

Purchase Reports From Reputable Market Research Publishers

Analyzing the Global Generics Industry 2014

Analyzing the Global Generics Industry 2014

  • $ 1 750
  • Industry report
  • August 2014
  • by Aruvian's R'search

In recent times there has been a growing focus on the generic drugs industry worldwide. The patent expiry of leading drugs in recent years and also the upcoming patent expiries has put a focus on the global ...

Global Generic Drugs Market 2014-2018

Global Generic Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing ...

Generic Drugs: Global collaboration opportunities

Generic Drugs: Global collaboration opportunities

  • $ 1 342
  • Industry report
  • January 2014
  • by Espicom Business Intelligence

Key facts, statistics and insights on 160 medium-sized generic manufacturers based in 42 countries! Collaboration is the key to growth With the recent economic turmoil affecting many markets around the ...

Global Markets For Generic Drugs

January 2014 $ 6 650

Global Hyaluronic Market 2012-2016

October 2013 $ 2 500

Related Market Segments :

Biosimilars
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.